Source: Diagnostic Pathology. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, ANTÍGENOS, CARCINOMA DE DUCTOS INFILTRANTE, BIOMARCADORES, IMUNOHISTOQUÍMICA
ABNT
SANTOS, Petra Barros dos et al. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study. Diagnostic Pathology, v. 7, 2012Tradução . . Disponível em: https://doi.org/10.1186/1746-1596-7-104. Acesso em: 05 dez. 2025.APA
Santos, P. B. dos, Zanetti, J. S., Silva, A. R., & Beltrão, E. I. C. (2012). Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study. Diagnostic Pathology, 7. doi:10.1186/1746-1596-7-104NLM
Santos PB dos, Zanetti JS, Silva AR, Beltrão EIC. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study [Internet]. Diagnostic Pathology. 2012 ; 7[citado 2025 dez. 05 ] Available from: https://doi.org/10.1186/1746-1596-7-104Vancouver
Santos PB dos, Zanetti JS, Silva AR, Beltrão EIC. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study [Internet]. Diagnostic Pathology. 2012 ; 7[citado 2025 dez. 05 ] Available from: https://doi.org/10.1186/1746-1596-7-104
